Search

11 Apr 2022: This initiative links the Universities of Cambridge, Lincoln, Reading, Hertfordshire, and East Anglia to drive commercialisation of agri-tech research and innovation.

9 May 2022: Hybridoma cell line producing IR 83-7 antibodies raised against the human insulin receptor, which are mouse monoclonal antibodies of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing IR CT-3 antibodies against the C-terminal portion of the human insulin receptor beta subunit, which are of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing IR 47-9 antibodies raised against the alpha subunit of the human insulin receptor,which are monoclonals of the IgG1 isotype.

28 Apr 2022: Cambridge Enterprise leads £1 million investment in 52 North Health, a UK and US-based med-tech start-up.

9 May 2022: Hybridoma cell line producing IR 18-45 antibodies against the beta subunit N-terminal region of the human insulin receptor, which are of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing IR 18-43 antibodies against the beta subunit N-terminal region of the human insulin receptor, which are of the IgG2a isotype.

9 May 2022: Hybridoma cell line producing IR 18-42 antibodies against the beta subunit N-terminal region of the human insulin receptor, which are of the IgG2b isotype.

9 May 2022: Hybridoma cell line producing IR 18-44 antibodies raised against beta subunit of the human insulin receptor which are mouse monoclonals of IgG2b isotype.

9 May 2022: Hybridoma cell line producing IR 83-14 antibodies against the alpha subunit of the human insulin receptor, which are mouse monoclonals of the IgG2a isotype.

9 May 2022: Hybridoma cell line producing IR 83-12 antibodies raised against the extracellular domain of the human insulin receptor, which are of the IgG1 isotype.

19 Jan 2022: We help University of Cambridge members commercialise their research by transforming their ideas into attractive opportunities.

9 May 2022: Hybridoma cell line producing IR 18-34 antibodies raised against the extracellular domain of the human insulin receptor which are of the IgG2a isotype.

9 May 2022: Hybridoma cell line producing IR 83-22 antibodies raised against the alpha subunit of the human insulin receptor, which are of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing IR 25-49 antibodies raised against the alpha subunit of the human insulin receptor, which are of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing IR 18-40 antibodies raised against the extracellular domain of the human insulin receptor, which are of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing YTS 154.7.7.10 antibodies raised against mouse Thy-1 which are rat monoclonal antibodies of the IgG2b isotype.

9 May 2022: Hybridoma cell line producing YTS 121.5.2 antibodies raised against mouse CD5 (lyt-1) which are rat monoclonal antibodies of the IgG2b isotype.

9 May 2022: Hybridoma cell line producing IR 18-146 antibodies raised against the extracellular domain of the human insulin receptor, which are of the IgG1 isotype.

15 Mar 2022: Kalamna, a University of Cambridge social enterprise, has developed an innovative phonics-based toolkit for learning Arabic.

9 May 2022: Hybridoma cell line producing YTS 156.7.7 antibodies raised against mouse CD8 (lyt-3) which are rat monoclonal antibodies of the IgG2b isotype.

7 Jan 2022: Find a selection of Johnian stories below, and read more in the Members’ news section of the College annual, The Eagle 2021, which will be published and mailed in October as ... Ahmed Fardin in College. Related events and news Skip related events and

9 May 2022: Hybridoma cell line producing YTS 105.18.10 antibodies raised against mouse CD8 (lyt-2) which are rat monoclonal antibodies of the IgG2a isotype.

9 May 2022: Hybridoma cell line producing YTA 3.1.2 antibodies raised against mouse CD4 Epitope B which are rat monoclonal antibodies of the IgG2b isotype.

9 May 2022: Hybridoma cell line producing YTS 191.1.2 antibodies raised against mouse CD4 epitope A which are rat monoclonal antibodies of the IgG2b isotype.

2 Dec 2022: Creating innovative proposals which could be used to translate academic insight into a tangible real-world outcomes.

11 Apr 2022: BOADICEA is a platform developed by researchers at the Department of Public Health and Primary Care that calculates the risk of breast cancer.

9 May 2022: Hybridoma cell line producing YTH470.5 antibodies raised against human beta 2-microglobulin which are rat monoclonal antibodies of the IgG2b isotype.

9 May 2022: Hybridoma cell line producing YTS 169.4.2.1 antibodies raised against mouse CD8 (lyt-2), which are rat monoclonal antibodies of the IgG2b isotype.

11 Apr 2022: Evidence included scientific papers, government reports, and local news articles. The close collaboration with local expert teams throughout the process brought great depth of knowledge, and ensured that visions remained focused

9 May 2022: University of Cambridge scientists has developed a neural network method that can predict the solubility of a protein from the amino acid sequence

17 Jan 2022: Carbon-Based Curiosities — Live with Regis and Kelly — A healthy balance of research news and assorted fluff, although Excimer swears more than Regis. ... news, lab research, and human interest stories.

2 Sep 2022: The College. Apply. Fellowships. People. News & Events. Affective Intelligence and Robotics: Minja Axelsson’s research on robots and wellbeing highlighted by the University.

19 Dec 2022: We have been licensing research tools for over a decade and can therefore fully support you through the process.

9 May 2022: KARPAS 422 Human B-cell Non-Hodgkin's Lymphoma cell line useful in oncology research, developed at the University of Cambridge.

9 May 2022: KARPAS 384 Human T-cell non-Hodgkin's Lymphoma cell line useful in oncology research, developed at the University of Cambridge.

9 May 2022: Hybridoma cell line producing YBM 5.10.4 antibodies raised against mouse heat stable antigen which are rat monoclonal antibodies of the IgG2c isotype.

9 May 2022: Hybridoma cell line producing YTS 177.9.6.1 antibodies raised against mouse CD4 epitope A which are rat monoclonal antibodies of the IgG2a isotype.

11 Apr 2022: HappyShield provides a barrier from splashes and sprays of infected bodily fluids and can be cleaned and reused indefinitely.

31 May 2022: News From the Wolfson Community - Spotlight on Fellows. Wolfson Welcomes Nine New World-Class Researchers. ... Art Exhibition. Wolfson Review News. This year’s edition will be emailed with postal copies sent on request.

9 May 2022: KARPAS 1106P Human B-cell Non-Hodgkin's Lymphoma cell line useful in oncology research, developed at the University of Cambridge.

25 Jan 2022: We nurture close connections and strong working relationships with a broad range of stakeholders in the wider Cambridge ecosystem.

7 Oct 2022: The College. Apply. Fellowships. People. News & Events. Environmental architecture: President’s research profiled by the University.

18 Jan 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. Science and Technology Facilities Council (STFC) Follow-on Fund (FoF). FoF is designed to fund a short term proof-of-concept project, which could lead on to further commercial

9 May 2022: Hybridoma cell line producing IRS 8-63 antibodies raised against rat insulin receptor substrate-1 which are mouse monoclonal antibodies of the IgG1 isotype.

31 May 2022: Please, enjoy reading about Wolfson College's latest news and all of our upcoming events as we look forward and celebrate the end of another wonderful academic year. ... Best wishes. Professor Jane Clarke. News From the Wolfson Community - Spotlight on

9 May 2022: Hybridoma cell line producing YTH 76.3 antibodies raised against human leukocyte antigen B (HLA-B) which are rat monoclonal antibodies of the IgG2a isotype.

11 Apr 2022: We ran a knowledge exchange programme on research commercialisation for three southern African universities in 2019.

27 Sep 2022: Cambridge’s leadership in knowledge exchange has been recognised in today's Knowledge Exchange Framework 2 (KEF2) results, published by Research England.

15 Nov 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 1 November 2022. Cambridge Enterprise licenses unique new device for cancer diagnosis. Share:. Transforming the process of prostate cancer diagnosis. This month will see the launch of a